Ercros, S.A. (BME:ECR)

Market Cap	315.91M +16.5%
Revenue (ttm)	600.27M -9.6%
Net Income	-55.04M
EPS	-0.60
Shares Out	91.44M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,263
Open	3.455
Previous Close	3.460
Day's Range	3.455 - 3.460
52-Week Range	2.230 - 3.475
Beta	0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Ercros

Ercros, S.A., together with its subsidiaries, manufactures and sells chemical and pharmaceutical products in Spain and internationally. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmaceuticals. The company offers ammonia, caustic soda and potash, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl chloride, potassium carbonate, PVC compounds, sodium chlorate, sodium chlorite, sodium hypochlorite, sulfuric acid, and vinyl chloride. It also provides ...

• Industry: Chemicals
• Sector: Materials
• Founded: 1817
• Employees: 1,329
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ECR

Financial Performance

In 2025, Ercros's revenue was 628.69 million, a decrease of -5.92% compared to the previous year's 668.22 million. Losses were -53.59 million, 359.7% more than in 2024.